Galectin Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update
November 08, 2016 08:00 ET
|
Galectin Therapeutics
NORCROSS, Ga., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer,...